Cargando…
Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation
AIMS: Mapping data of human ventricular fibrillation (VF) are limited. We performed detailed mapping of the activities underlying the onset of VF and targeted ablation in patients with structural cardiac abnormalities. METHODS AND RESULTS: We evaluated 54 patients (50 ± 16 years) with VF in the sett...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934691/ https://www.ncbi.nlm.nih.gov/pubmed/35134898 http://dx.doi.org/10.1093/eurheartj/ehab893 |
_version_ | 1784671898268860416 |
---|---|
author | Haissaguerre, Michel Cheniti, Ghassen Hocini, Meleze Sacher, Frederic Ramirez, F. Daniel Cochet, Hubert Bear, Laura Tixier, Romain Duchateau, Josselin Walton, Rick Surget, Elodie Kamakura, Tsukasa Marchand, Hugo Derval, Nicolas Bordachar, Pierre Ploux, Sylvain Takagi, Takamitsu Pambrun, Thomas Jais, Pierre Labrousse, Louis Strik, Mark Ashikaga, Hiroshi Calkins, Hugh Vigmond, Ed Nademanee, Koonlawee Bernus, Olivier Dubois, Remi |
author_facet | Haissaguerre, Michel Cheniti, Ghassen Hocini, Meleze Sacher, Frederic Ramirez, F. Daniel Cochet, Hubert Bear, Laura Tixier, Romain Duchateau, Josselin Walton, Rick Surget, Elodie Kamakura, Tsukasa Marchand, Hugo Derval, Nicolas Bordachar, Pierre Ploux, Sylvain Takagi, Takamitsu Pambrun, Thomas Jais, Pierre Labrousse, Louis Strik, Mark Ashikaga, Hiroshi Calkins, Hugh Vigmond, Ed Nademanee, Koonlawee Bernus, Olivier Dubois, Remi |
author_sort | Haissaguerre, Michel |
collection | PubMed |
description | AIMS: Mapping data of human ventricular fibrillation (VF) are limited. We performed detailed mapping of the activities underlying the onset of VF and targeted ablation in patients with structural cardiac abnormalities. METHODS AND RESULTS: We evaluated 54 patients (50 ± 16 years) with VF in the setting of ischaemic (n = 15), hypertrophic (n = 8) or dilated cardiomyopathy (n = 12), or Brugada syndrome (n = 19). Ventricular fibrillation was mapped using body-surface mapping to identify driver (reentrant and focal) areas and invasive Purkinje mapping. Purkinje drivers were defined as Purkinje activities faster than the local ventricular rate. Structural substrate was delineated by electrogram criteria and by imaging. Catheter ablation was performed in 41 patients with recurrent VF. Sixty-one episodes of spontaneous (n = 10) or induced (n = 51) VF were mapped. Ventricular fibrillation was organized for the initial 5.0 ± 3.4 s, exhibiting large wavefronts with similar cycle lengths (CLs) across both ventricles (197 ± 23 vs. 196 ± 22 ms, P = 0.9). Most drivers (81%) originated from areas associated with the structural substrate. The Purkinje system was implicated as a trigger or driver in 43% of patients with cardiomyopathy. The transition to disorganized VF was associated with the acceleration of initial reentrant activities (CL shortening from 187 ± 17 to 175 ± 20 ms, P < 0.001), then spatial dissemination of drivers. Purkinje and substrate ablation resulted in the reduction of VF recurrences from a pre-procedural median of seven episodes [interquartile range (IQR) 4–16] to 0 episode (IQR 0–2) (P < 0.001) at 56 ± 30 months. CONCLUSIONS: The onset of human VF is sustained by activities originating from Purkinje and structural substrate, before spreading throughout the ventricles to establish disorganized VF. Targeted ablation results in effective reduction of VF burden. KEY QUESTION: The initial phase of human ventricular fibrillation (VF) is critical as it involves the primary activities leading to sustained VF and arrhythmic sudden death. The origin of such activities is unknown. KEY FINDING: Body-surface mapping shows that most drivers (≈80%) during the initial VF phase originate from electrophysiologically defined structural substrates. Repetitive Purkinje activities can be elicited by programmed stimulation and are implicated as drivers in 37% of cardiomyopathy patients. TAKE-HOME MESSAGE: The onset of human VF is mostly associated with activities from the Purkinje network and structural substrate, before spreading throughout the ventricles to establish sustained VF. Targeted ablation reduces or eliminates VF recurrence. |
format | Online Article Text |
id | pubmed-8934691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89346912022-03-21 Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation Haissaguerre, Michel Cheniti, Ghassen Hocini, Meleze Sacher, Frederic Ramirez, F. Daniel Cochet, Hubert Bear, Laura Tixier, Romain Duchateau, Josselin Walton, Rick Surget, Elodie Kamakura, Tsukasa Marchand, Hugo Derval, Nicolas Bordachar, Pierre Ploux, Sylvain Takagi, Takamitsu Pambrun, Thomas Jais, Pierre Labrousse, Louis Strik, Mark Ashikaga, Hiroshi Calkins, Hugh Vigmond, Ed Nademanee, Koonlawee Bernus, Olivier Dubois, Remi Eur Heart J Clinical Research AIMS: Mapping data of human ventricular fibrillation (VF) are limited. We performed detailed mapping of the activities underlying the onset of VF and targeted ablation in patients with structural cardiac abnormalities. METHODS AND RESULTS: We evaluated 54 patients (50 ± 16 years) with VF in the setting of ischaemic (n = 15), hypertrophic (n = 8) or dilated cardiomyopathy (n = 12), or Brugada syndrome (n = 19). Ventricular fibrillation was mapped using body-surface mapping to identify driver (reentrant and focal) areas and invasive Purkinje mapping. Purkinje drivers were defined as Purkinje activities faster than the local ventricular rate. Structural substrate was delineated by electrogram criteria and by imaging. Catheter ablation was performed in 41 patients with recurrent VF. Sixty-one episodes of spontaneous (n = 10) or induced (n = 51) VF were mapped. Ventricular fibrillation was organized for the initial 5.0 ± 3.4 s, exhibiting large wavefronts with similar cycle lengths (CLs) across both ventricles (197 ± 23 vs. 196 ± 22 ms, P = 0.9). Most drivers (81%) originated from areas associated with the structural substrate. The Purkinje system was implicated as a trigger or driver in 43% of patients with cardiomyopathy. The transition to disorganized VF was associated with the acceleration of initial reentrant activities (CL shortening from 187 ± 17 to 175 ± 20 ms, P < 0.001), then spatial dissemination of drivers. Purkinje and substrate ablation resulted in the reduction of VF recurrences from a pre-procedural median of seven episodes [interquartile range (IQR) 4–16] to 0 episode (IQR 0–2) (P < 0.001) at 56 ± 30 months. CONCLUSIONS: The onset of human VF is sustained by activities originating from Purkinje and structural substrate, before spreading throughout the ventricles to establish disorganized VF. Targeted ablation results in effective reduction of VF burden. KEY QUESTION: The initial phase of human ventricular fibrillation (VF) is critical as it involves the primary activities leading to sustained VF and arrhythmic sudden death. The origin of such activities is unknown. KEY FINDING: Body-surface mapping shows that most drivers (≈80%) during the initial VF phase originate from electrophysiologically defined structural substrates. Repetitive Purkinje activities can be elicited by programmed stimulation and are implicated as drivers in 37% of cardiomyopathy patients. TAKE-HOME MESSAGE: The onset of human VF is mostly associated with activities from the Purkinje network and structural substrate, before spreading throughout the ventricles to establish sustained VF. Targeted ablation reduces or eliminates VF recurrence. Oxford University Press 2022-02-04 /pmc/articles/PMC8934691/ /pubmed/35134898 http://dx.doi.org/10.1093/eurheartj/ehab893 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Haissaguerre, Michel Cheniti, Ghassen Hocini, Meleze Sacher, Frederic Ramirez, F. Daniel Cochet, Hubert Bear, Laura Tixier, Romain Duchateau, Josselin Walton, Rick Surget, Elodie Kamakura, Tsukasa Marchand, Hugo Derval, Nicolas Bordachar, Pierre Ploux, Sylvain Takagi, Takamitsu Pambrun, Thomas Jais, Pierre Labrousse, Louis Strik, Mark Ashikaga, Hiroshi Calkins, Hugh Vigmond, Ed Nademanee, Koonlawee Bernus, Olivier Dubois, Remi Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
title | Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
title_full | Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
title_fullStr | Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
title_full_unstemmed | Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
title_short | Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
title_sort | purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934691/ https://www.ncbi.nlm.nih.gov/pubmed/35134898 http://dx.doi.org/10.1093/eurheartj/ehab893 |
work_keys_str_mv | AT haissaguerremichel purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT chenitighassen purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT hocinimeleze purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT sacherfrederic purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT ramirezfdaniel purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT cochethubert purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT bearlaura purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT tixierromain purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT duchateaujosselin purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT waltonrick purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT surgetelodie purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT kamakuratsukasa purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT marchandhugo purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT dervalnicolas purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT bordacharpierre purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT plouxsylvain purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT takagitakamitsu purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT pambrunthomas purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT jaispierre purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT labrousselouis purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT strikmark purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT ashikagahiroshi purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT calkinshugh purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT vigmonded purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT nademaneekoonlawee purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT bernusolivier purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation AT duboisremi purkinjenetworkandmyocardialsubstrateattheonsetofhumanventricularfibrillationimplicationsforcatheterablation |